# EDGAR Filing Document

**Accession Number:** 0001872529
**File Stem:** 0001213900-26-015510
**Filing Date:** 2026-2
**Character Count:** 2431
**Document Hash:** 8299043dfc32f5ddf8d5c78d81f8b0fb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-015510.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0001213900-26-015510

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260212

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MDxHealth SA
- **CENTRAL INDEX KEY:** 0001872529
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C9

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** CAP BUSINESS CENTER
- **STREET 2:** RUE D'ABHOOZ, 31, B-4040
- **CITY:** HERSTAL
- **STATE:** C9
- **ZIP:** 00000
- **BUSINESS PHONE:** 949-271-9221

**MAIL ADDRESS:**
- **STREET 1:** CAP BUSINESS CENTER
- **STREET 2:** RUE D'ABHOOZ, 31, B-4040
- **CITY:** HERSTAL
- **STATE:** C9
- **ZIP:** 00000

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MDx Health SA
- **DATE OF NAME CHANGE:** 20210713

MDxHealth SA

Zone Industrielle des Hauts-Sarts<br> 4040 Herstal, Belgium

February 12, 2026

Securities and Exchange Commission<br> 100 F Street, N.E.<br> Washington, D.C. 20549

Attention: Margaret Sawicki

Re: MDxHealth SA

Registration Statement on Form F-3 (File No. 333-292463)

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), registrant MDxHealth SA (the "Registrant") hereby respectfully requests that the above-referenced Registration Statement on Form F-3 be declared effective at 4:00 p.m., Eastern Time, on Tuesday, February 17, 2026, or as soon thereafter as is practicable or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission.

Please direct any questions regarding this request to Mark Busch of K&L Gates LLP ((704) 331-7440; mark.busch@klgates.com). In addition, please notify Mr. Busch when this request for acceleration has been granted.

We understand that the staff of the United States Securities and Exchange Commission will consider this request as confirmation by the Registrant that it is aware of its responsibilities under the Securities Act as they relate to the issuance of the securities covered by the Registration Statement.

Sincerely,

---

| |
|:---|
| /s/ Joseph Sollee |
| Joseph Sollee |
| EVP Corporate Development and General Counsel |

---